Fact Flyers related to CMC Biologics
Fact Flyer
Chemistry, manufacturing, and controls (CMC) describe critical activities during development and regulatory approval of pharmaceutical and biopharmaceutical products. PharmaLex’s data strategy and statistics dedicated team specializes in leveraging an integrated data-and-analytics approach to accelerate quality throughout the drug development and production lifecycle.
Fact Flyer
PharmaLex offers full lifecycle management for the submission process with flexible options for report-level publishing, compilation of major applications (IND, NDA, BLA) and lifecycle maintenance. Our regulatory affairs professionals are experienced in an array of electronic formats, including electronic Common Technical Documents (eCTD), and Structured Product Labeling (SPL).
Fact Flyer
Meetings with the leadership and review staff of the US Food and Drug Administration (FDA) are one of the most important resources available to sponsors seeking agency approval in the US. PharmaLex recommends holding face-to-face and teleconference meetings with FDA throughout the product development timeline.
Fact Flyer
Our CMC group provides regulatory guidance in setting specifications, method development and validation of documentation. We can help you build a positive relationship with…
Fact Flyer
Implementing a sustainable approach to the CMC compliance process. CMC compliance is an important component in the lifecycle of a medicinal product, but is one that is continually challenged by many factors.